Coronary artery bypass grafting under sole Impella 5.0 support for patients with severely depressed left ventricular function

Shintaro Katahira, Yukiharu Sugimura, Arash Mehdiani, Alexander Assmann, Philipp Rellecke, Igor Tudorache, Udo Boeken, Hug Aubin, Artur Lichtenberg, Payam Akhyari

Research output: Contribution to journalArticlepeer-review

Abstract

Selection of the ideal surgical procedure for coronary revascularization in patients with severe cardiac dysfunction at times may represent a challenge. In recent years, with the advent of surgical large microaxial pumps, e.g., Impella 5.0 (Abiomed Inc., Boston, USA), specific support and effective unloading of the left ventricle has become available. In the interventional field, good results have been achieved with smaller microaxial pumps in the setting of so-called protected percutaneous coronary intervention. In this study, we would like to share our early experience with surgical coronary revascularization under the sole support of Impella 5.0, omitting the use of heart–lung machine in three cases of severe cardiac dysfunction due to complex ischemic heart disease. Effective circulatory support intraoperatively and postoperatively speaks in favor of this technique in selected patients.

Original languageEnglish
JournalJournal of Artificial Organs
DOIs
Publication statusAccepted/In press - 2021

Keywords

  • Impella 5.0
  • Ischemic cardiomyopathy
  • Ischemic heart disease
  • Low ejection fraction
  • OPCAB

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Coronary artery bypass grafting under sole Impella 5.0 support for patients with severely depressed left ventricular function'. Together they form a unique fingerprint.

Cite this